Position in TNYA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$95,500
+$88,542 QoQ
Shares Held
138,006
+1030.4% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 103 holders
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TNYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,193,805,089 across 258 Biotechnology names. TNYA ranks #237 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in TNYA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $95,500 | 138,006 | Shares | Defined | 2026-05-12 | |
| 2025-03-31 | $6,958 | 12,209 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $18,410 | 12,876 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $21,560 | 11,172 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $36,728 | 11,848 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $62,372 | 11,926 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $41,209 | 12,719 | Shares | Defined | 2024-02-13 | |
| 2023-06-30 | $2,757,449 | 469,753 | Shares | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||